Business Description
Hubei Goto Biopharm Co Ltd
ISIN : CNE100004K94
Share Class Description:
SZSE:300966: Class ACompare
Compare
Traded in other countries / regions
300966.China IPO Date
2021-04-09Description
Hubei Goto Biopharm Co Ltd is engaged in the research and development, production, and sales of steroidal hormone drug raw materials.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.88 | |||||
Debt-to-EBITDA | 27.67 | |||||
Interest Coverage | 3.48 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.29 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.3 | |||||
3-Year EBITDA Growth Rate | -20 | |||||
3-Year EPS without NRI Growth Rate | -30 | |||||
3-Year FCF Growth Rate | -269.1 | |||||
3-Year Book Growth Rate | 10.1 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.17 | |||||
9-Day RSI | 30.35 | |||||
14-Day RSI | 36.28 | |||||
6-1 Month Momentum % | -5.66 | |||||
12-1 Month Momentum % | -22.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 353.64 | |||||
Days Sales Outstanding | 127.92 | |||||
Days Payable | 304.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.11 | |||||
Forward Dividend Yield % | 0.11 | |||||
5-Year Yield-on-Cost % | 0.11 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -5.84 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.39 | |||||
Operating Margin % | 7.78 | |||||
Net Margin % | 3.96 | |||||
FCF Margin % | -40.93 | |||||
ROE % | 2.38 | |||||
ROA % | 0.99 | |||||
ROIC % | 2.99 | |||||
ROC (Joel Greenblatt) % | 2.18 | |||||
ROCE % | 1.79 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 74.65 | |||||
PE Ratio without NRI | 54.89 | |||||
PS Ratio | 2.86 | |||||
PB Ratio | 1.8 | |||||
Price-to-Tangible-Book | 1.9 | |||||
Price-to-Operating-Cash-Flow | 16.19 | |||||
EV-to-EBIT | 81.47 | |||||
EV-to-EBITDA | 81.47 | |||||
EV-to-Revenue | 4.35 | |||||
EV-to-FCF | -11.47 | |||||
Price-to-Graham-Number | 2.15 | |||||
Earnings Yield (Greenblatt) % | 1.23 | |||||
FCF Yield % | -13.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Goto Biopharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 569.204 | ||
EPS (TTM) (Â¥) | 0.2 | ||
Beta | 1 | ||
Volatility % | 40.49 | ||
14-Day RSI | 36.28 | ||
14-Day ATR (Â¥) | 0.636489 | ||
20-Day SMA (Â¥) | 16.1455 | ||
12-1 Month Momentum % | -22.91 | ||
52-Week Range (Â¥) | 12.03 - 28.78 | ||
Shares Outstanding (Mil) | 115.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hubei Goto Biopharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hubei Goto Biopharm Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Hubei Goto Biopharm Co Ltd Frequently Asked Questions
What is Hubei Goto Biopharm Co Ltd(SZSE:300966)'s stock price today?
The current price of SZSE:300966 is ¥14.93. The 52 week high of SZSE:300966 is ¥28.78 and 52 week low is ¥12.03.
When is next earnings date of Hubei Goto Biopharm Co Ltd(SZSE:300966)?
The next earnings date of Hubei Goto Biopharm Co Ltd(SZSE:300966) is .
Does Hubei Goto Biopharm Co Ltd(SZSE:300966) pay dividends? If so, how much?
The Dividend Yield %  of Hubei Goto Biopharm Co Ltd(SZSE:300966) is 0.11% (As of Today), Highest Dividend Payout Ratio of Hubei Goto Biopharm Co Ltd(SZSE:300966) was 0.43. The lowest was 0.43. And the median was 0.43. The  Forward Dividend Yield % of Hubei Goto Biopharm Co Ltd(SZSE:300966) is 0.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |